Originally published In Press as doi:10.1074/jbc.M200264200 on March 15, 2002
J. Biol. Chem., Vol. 277, Issue 22, 20051-20058, May 31, 2002
A Novel Prokaryotic Phospholipase A2
CHARACTERIZATION, GENE CLONING, AND SOLUTION STRUCTURE*
Masanori
Sugiyama
§,
Kazuhiro
Ohtani
,
Miho
Izuhara
,
Tohru
Koike
,
Koji
Suzuki¶
,
Shigeyuki
Imamura¶, and
Hideo
Misaki¶
From the
Institute of Pharmaceutical Sciences,
Faculty of Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku,
Hiroshima 734-8551, and ¶ Diagnostic Research and Development,
Fine Chemicals and Diagnostics Division, Asahi Kasei Corp., 632-1,
Mifuku, Ohito, Shizuoka 410-2321, Japan
Received for publication, January 10, 2002, and in revised form, February 27, 2002
 |
ABSTRACT |
Until now, phospholipase A2
(PLA2; EC 3.1.14) has been found only from eukaryotic
sources. In the present study, we found a secreted PLA2,
which is produced by a soil bacterium, Streptomyces violaceoruber A-2688, demonstrating that the enzyme is the
first phospholipase A2 identified in prokaryote. After
characterization of the novel PLA2, a gene encoding the
enzyme was cloned, sequenced, and overexpressed using a
Streptomyces host-vector system. The amino acid sequence
showed that the prokaryotic PLA2 has only four cysteines
and less homology to the eukaryotic ones, which have 12-16 cysteines.
The solution structures of the prokaryotic PLA2, bound and
unbound with calcium(II) ion, were determined by using the NMR
technique and structure calculation. The overall structure of the
S. violaceoruber PLA2, which is composed of
only five
-helices, is completely different from those of eukaryotic PLA2s, which consist of
-sheets and
-helices. The
structure of the calcium-binding domain is obviously distinct from that without the ion; the ligands for the calcium(II) ion are the two carboxylates of Asp43 (monodentate) and Asp65
(bidentate), the carbonyl oxygen of Leu44, and three water
molecules. A calcium-binding experiment showed that the calcium
dissociation constant (~5 mM) for the prokaryotic PLA2 is much larger than those of eukaryotic ones.
 |
INTRODUCTION |
Phospholipase A2
(PLA21; EC
3.1.1.4), which hydrolyzes the 2-acyl ester bonds of
1,2-diacylglycero-3-phospholipids (Fig. 1), is intra- or extracellularly produced
by eukaryotic cells (1). Intracellular PLA2s are divided
into calcium-dependent and calcium-independent types. Since
a certain calcium-dependent intracellular PLA2
catalyzes the release of arachidonic acid and participates in the
inflammatory cascade, the development of drugs inactivating the human
PLA2 is of great pharmacological interest (2-4).
All secreted PLA2s require calcium(II) ion for the
expression of catalytic activity. These PLA2s have been
grouped into three classes based on their primary structures (5). Class
I enzymes are found in mammalian pancreatic juice and cobra venom.
Class II enzymes are contained in synovial fluid and rattlesnake venom. The PLA2s included in both classes have a molecular mass of
14 kDa and mutually exhibit high similarities on their primary
structures. A PLA2 contained in bee venom has a molecular
mass of 12 kDa and is classified into class III.
With respect to the physiological functions of PLA2, for
example, snake venom PLA2s have evolved into extremely
potent toxins displaying neurotoxic, myotoxic, anticoagulant, and
proinflammatory effects (6, 7). Pancreatic PLA2, secreted
from the pancreatic acinar cells as an inactive zymogen, functions as a
digestive enzyme after proteolytic cleavage of the pro form by trypsin
to the mature form (8). We have shown that the mature form of human
pancreatic PLA2, but not its precursor form, stimulates the
proliferation of a human pancreatic cancer cell line (9). We have found
that the proliferation is mediated via the activation of
mitogen-activated protein kinase after binding of the mature PLA2 to its specific receptor (10) but not via its
catalytic property (11). In the proliferation experiment, since the
bacterial PLA2 was ineffective, we examined the tertiary
structural difference for the binding of PLA2 to the
specific receptor between the human pancreatic and bacterial
PLA2s.
Several structural studies of PLA2 in solution (12) and in
crystal (13-20) have been reported. The crystal structural studies of
secreted PLA2s have shown that the overall structures of
class I PLA2s are similar to those of class II enzymes.
Although the primary structures of class I and class II enzymes are
distinct from that of class III, x-ray crystallographic analyses (20) show that the catalytic and calcium-binding sites in class I and class
II are conserved in class III.
In recent years, many additional forms of secreted PLA2s
have been discovered. These additional forms are clearly related to
classes I, II, and III PLA2s but do not easily fit into
those groups. This has led to the establishment of classes V, IX, X, XI
(21), and XII (22). According to this classification, cytosolic PLA2s are divided into classes IV, VI, VII, and VIII (21).
For example, a PLA2, conodipine-M, isolated from the venom
of the marine snail Conus magus, has been classified as
class IX (21, 23).
In the present study, we investigated the enzymatic properties of the
Streptomyces violaceoruber PLA2, which is the
first phospholipase A2 discovered in prokaryote.
Furthermore, we cloned and sequenced a gene encoding the bacterial
PLA2. The overproduction of the S. violaceoruber
PLA2 using a Streptomyces host-vector system
allowed us to determine the three-dimensional structure of the enzyme
in solution by NMR as well as the x-ray crystal structure, which is
described the accompanying paper (38).
 |
EXPERIMENTAL PROCEDURES |
General Information--
All reagents and solvents used were of
analytical reagent grade and were used without further purification.
All aqueous solutions were prepared with deionized and distilled water.
Good's buffers, PIPES, and EPPS from Dojindo,
L-
-phosphatidyl choline (egg yolk) from Nakalai Tesque,
and 1,2-dipalmitoyl-L-
-phosphatidylcholine (1,2-dipalmitoyl-glycero-3-phosphocholine) and
palmitoyl-L-
-lysophosphatidylcholine (1-palmitoyl-glycero-3-phosphocholine) from Sigma were commercially available. The pH electrode system (DKK Corp. IOL-40 with a Ross combination pH electrode 8102BN) was calibrated by using standard pH
buffers (pH 4 and 7; Horiba Ltd.) at 25.0 and 35.0 °C with stirring.
Proton NMR (500-MHz) spectra were determined on a JEOL Lambda-500
spectrometer, where the solvent d4-methanol (
3.30) was used as the standard signal:
1,2-dipalmitoyl-L-
-phosphatidylcholine,
0.89 (6H,
CCH3), 1.28 (48H, CCH2C), 1.59 (4H,
CH2CCOO), 2.31 (4H, CH2COO), 3.22 (9H,
NCH3), 3.64 (2H, CCH2N), 3.99 (2H,
CCCH2OP), 4.17 (1H, CHCC), 4.26 (2H, POCH2CN),
4.43 (1H, CHCC), and 5.24 (1H, CCHC);
1-palmitoyl-L-
-lysophosphatidylcholine,
0.89 (3H, CCH3), 1.28 (24H, CCH2C), 1.61 (4H, CH2CCOO), 2.35 (4H, CH2COO), 3.22 (9H,
NCH3), 3.63 (2H, CCH2N), 3.89 (2H,
CCCH2OP), 3.97 (1H, CCHC), 4.11 (1H, CHCC), 4.17 (1H,
CHCC), and 4.28 (2H, POCH2CN).
Screening of PLA2-producing Microorganisms--
Many
strains of the genus Streptomyces having phospholipase
activity, isolated from a soil sample in Japan, are stocked in the
Diagnostic Research and Development Department, Fine Chemicals and
Diagnostics Division, Asahi Kasei Co., Japan. To screen candidates of
PLA2-producing microorganisms, we examined whether
PLA2 activity was observed in the supernatant fluid
obtained by growing the stock strains in a liquid medium consisting of
Tryptic soy broth (Difco). The supernatant was incubated with a
PLA2 assay medium (1.0 ml) consisting of a 0.10 M PIPES buffer (pH 7.5 adjusted with NaOH), 6.0 mM 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (Avanti
Polar Lipids, Inc.), and 10 mM CaCl2. The
mixture was incubated at 40 °C for 1 h with gentle shaking, and
then 0.10 ml of 5.0 M HCl and 1.5 ml of hexane were added.
After a portion (150 µl) of the hexane phase was dried up, the
residue was dissolved in 0.20 ml of hexane-saturated methanol
containing 50 µl of trimethylsilyldiazomethane as a methylating
reagent. The obtained oleic methyl ester was subjected to a general gas
chromatography. The bee venom PLA2 (Sigma) was used for a
control experiment.
Medium and Culture Conditions--
S. violaceoruber
A-2688 was grown in 3% (w/v) tryptic soy broth at 28 °C for 2 days
for seed culture. The seed culture was transferred into 20 liters of a
liquid medium containing 2% (w/v) dextrin, 1%(w/v) glucose,
0.5% (w/v) soy bean powder, 1% (w/v) polypeptone, 0.3% (w/v) KCl,
0.1% (w/v) MgSO4, 0.1% (w/v)
K2HPO4, and a 0.1% (v/v) trace element
solution (40 mg of ZnCl2, 0.20 g of
FeCl3·6H2O, 10 mg of
CuCl2·2H2O, 10 mg of
MnCl2·4H2O, 10 mg of
Na2B4O7·4H2O, and 10 mg
(NH4)6Mo7O24·4H2O
in 1 liter of H2O) and grown at 28 °C for 4 days.
Acetone (0.45 volume) was added to the supernatant fluid by
centrifuging the culture broth at 10,000 × g for 10 min. The resulting supernatant, obtained by the same speed
centrifugation, was again added with 2.8 volumes of acetone and
centrifuged to collect the precipitate. The precipitate was dissolved
into a 10 mM Tris-HCl buffer (pH 8.0) containing 20 mM CaCl2 and subjected to a Sephadex G-25
column (
4.5 × 50 cm) equilibrated with a 10 mM
citrate-NaOH buffer (pH 5.0). The active fraction was applied on a
CM-Sepharose CL-6B column (
0.5 × 30 cm) equilibrated with the
10 mM citrate buffer and eluted with a linear gradient of
the 10 mM citrate buffer containing 0-0.5 M
KCl. After removing the salt using the 10 mM Tris-HCl buffer, the enzyme fraction was applied on a DEAE-Sepharose CL-6B column (
2.6 × 30 cm) equilibrated with the 10 mM
Tris-HCl buffer. The active fraction was obtained by a gradient elution
with the 10 mM Tris-HCl buffer containing 0-1
M KCl. The active fraction was dialyzed against the 10 mM Tris-HCl buffer at 4 °C overnight, lyophilized, and
stored in a refrigerator until use.
On the other hand, the cloned PLA2 gene was expressed in
S. lividans TK24 as a host cell (24). S. lividans
carrying the PLA2 gene-inserted plasmid was grown in 20 liters of 3% (w/v) tryptic soy broth supplemented with 10 µg/ml
thiostrepton, which is necessary to maintain the
plasmid-harboring thiostrepton resistance gene as a selection
marker in the Streptomyces vector pIJ680 (25). After
centrifugation at 8,500 × g for 20 min, the
supernatant fluid was added with solid
(NH4)2SO4 to reach 40% saturation. The resulting precipitate was removed by centrifugation at 8,500 × g for 20 min. The precipitate, formed by the further
addition of (NH4)2SO4 to reach 50%
saturation to the supernatant, was collected, dissolved in a 20 mM Tris-HCl buffer (pH 8.0), and dialyzed against the same
buffer. The dialysate was applied on a Q-Sepharose Fast Flow column
(
5.0 × 15 cm; Amersham Biosciences) equilibrated with 20 mM Tris-HCl buffer, and eluted with a linear gradient of
0-1.0 M NaCl in the 20 mM Tris-HCl buffer. The
active fractions were collected and dialyzed against the 20 mM Tris-HCl buffer and then lyophilized. The lyophilized
PLA2 was dispersed in mannitol as a stabilizer and kept
below
18 °C.
An Assay Method of PLA2 Activity--
In order to
measure PLA2 activity, we prepared a reaction mixture
consisting of solutions I and II. Solution I (0.50 ml) contained 0.20 ml of a 0.20 M Tris-HCl buffer (pH 8.0), 0.50 ml of 20 mM 1,2-dipalmitoyl-glycero-3-phosphocholine dissolved in
2% (w/v) Triton X-100, 25 µl of 1.0 M CaCl2,
10 µl of 0.20 M ATP, 20 µl of 0.10 M CoA,
50 µl of acyl-CoA synthetase (Asahi Kasei Co., catalog no. T-16; 10.6 units/ml), and 145 µl of distilled water. Solution II (0.50 ml)
consisted of 40 µl of a 0.20 M PIPES buffer (pH 7.5 adjusted with NaOH), 0.10 ml of 0.3% (w/v) 4-aminoantipyrine, 0.10 ml
of 0.20% (w/v) phenol, 45 µl of peroxidase (50 units/ml; Sigma, type
II P-8250), 50 µl of acyl-CoA oxidase (Asahi Kasei Co., catalog no.
T-17; 300 units/ml), 10 µl of 10% (w/v) Triton X-100, 50 µl of
0.20 M ATP, 5.0 µl of 10 mM FAD, and 0.10 ml
of distilled water. This assay is based on the increase in absorbance at 500 nm due to quinoneimine dye, which is finally formed when PLA2 liberates fatty acid as a result of hydrolysis of
lecithin as a substrate. The addition of acyl-coenzyme A (acyl-CoA)
synthetase with CoA and ATP catalyzes the formation of acyl-CoA in the
presence of the fatty acid. The addition of acyl-CoA oxidase
contributes to form H2O2 in the presence of the
resulting acyl-CoA. The dye, 4-quinoneimine, is finally generated from
4-aminoantipyrine as a result of catalysis by peroxidase in the
presence of phenol and H2O2. An enzyme fraction
(0.50 ml) was added to solution I (500 µl) preincubated at 37 °C
for 5 min, and incubated at 37 °C for 10 min. The reaction mixture
was added in 0.50 ml of 20 mM N-ethylmaleimide
and then mixed with solution II (0.50 ml). After incubation at 37 °C
for 5 min, 1.5 ml of 5% (w/v) SDS containing 0.10 M EDTA
was added to stop the reaction, and then absorbance at 500 nm was
measured. One unit of PLA2 activity was defined as the
amount of enzyme that liberates 1.0 µmol of fatty acid from lecithin
per min at 37 °C.
Determination of the Amino Acid Sequence of
PLA2--
After the purified PLA2 (0.50 mg)
had been dissolved in a 0.80 M Tris-HCl buffer (pH 8.0) and
incubated at 90 °C for 15 min, the sample was digested with
endoprotease Asn-N (Roche Molecular Biochemicals) at 37 °C
overnight. The digest was mixed with 0.60 ml of 6.0 M
guanidine HCl and subjected to HPLC using an ODS column (Cosmoseal
C-18, Nakalai Tesque, Japan). On the other hand, the purified
PLA2 (0.50 mg), dissolved in 0.60 ml of 6.0 M
guanidine HCl, was adjusted to pH 9.0 with a 0.80 M Tris
base. After incubation at 90 °C for 15 min, the sample was cooled
down to room temperature, and then lysyl endopeptidase (5.0 µg; Wako,
Japan) was added. After incubation at 37 °C for 150 min, the
resulting peptide fragments were purified by using HPLC carrying the
same ODS column as used above. The N-terminal amino acid sequence of
the peptides was determined using an automated protein sequencer
(Shimadzu PSQ-1).
Cloning of a PLA2 Encoding Gene--
To make a
genomic library in Escherichia coli TG1 of S. violaceoruber A-2688, the chromosomal DNA was isolated and
digested with KpnI and inserted into the
KpnI-digested pUC118. To obtain the S. violaceoruber PLA2 gene, four kinds of mixed probes
(probes 1-4), shown in Fig. 2, were designed and synthesized, based on the N-terminal sequences of the S. violaceoruber
PLA2 digested with or without peptidases described above.
The library, prepared in E. coli TG1, was screened using the
mixed probes labeled with
-32P and by colony hybridization.
Transformation in Streptomyces--
The experiment of the
introduction of a plasmid carrying the PLA2 gene into the
S. lividans cells was conducted mainly according to the
reported method (25). This method is based on the discovery that
protoplasts, prepared from the Streptomyces mycelium, are transformed by a Streptomyces plasmid DNA at a high
frequency in the presence of polyethylene glycol. The transformed
protoplasts are regenerated to form colonies on a regeneration medium,
designated R5.
Determination of the Calcium Dissociation Constant of
PLA2--
The calcium dissociation constant
(Kd) was determined by the following kinetic
procedure. An aqueous solution containing 1.7 mg/ml (~2
mM) L-
-phosphatidylcholine (PC) from egg
yolk, a 1.0 mM EPPS buffer, 10 mM Triton X-100,
0.10 M NaCl, and CaCl2 (1.0, 2.0, 3.0, 5.0, 10, or 20 mM) was prepared as a test solution. After the
solution had been sonicated for more than 10 min at 35 °C, the pH
was adjusted to 8.00 with 0.10 M NaOH. The PC hydrolysis catalyzed by the S. violaceoruber PLA2 was
followed by the pH decrease that results from the release of fatty acid
(pKa ~5) in the 2-position of PC. After an aqueous
solution (10 µl) containing 23 µM PLA2 and
1.0 mM ethylenediamine tetraacetic acid disodium salt had
been rapidly injected in the test solution (10 ml) at 25 and 35 °C
under a nitrogen atmosphere (99.999% purity), the pH was immediately
recorded. The time (T) for the pH drop from 7.90 to 7.70 was
measured in the presence of calcium(II) ion (e.g.
T = 120 s at [Ca2+] = 10 mM and 35 °C), where the PC hydrolysis rate
(V) at pH 7.8 is defined as 1/T
(s-1). Background PC-hydrolysis in the absence of
calcium(II) ion was determined under the same condition, where no pH
drop was observed within 10 min. The same pH drop corresponds to ~40
µM H+ release, which was determined by pH
titration with 2.0 mM HCl. All kinetic experiments were run
in triplicate, and the obtained hydrolysis rates were reproducible
within 10%.
NMR Spectroscopy--
The recombinant PLA2 dispersed
in mannitol was dialyzed against distilled water for 48 h at room
temperature. The dialysate was freeze-dried and then subjected to the
preparation of a test solution of 3.0 mM
calcium-free PLA2 in a 20 mM phosphate
buffer (pD 7.6 in D2O or pH 7.6 in 10% (v/v)
D2O/H2O). The same buffer containing 20 mM CaCl2 was used for the calcium-bound
PLA2. The pD value in D2O was corrected for the
deuterium isotope effect using pD = (pH meter reading) + 0.4. All
measurements were run on a JEOL Lambda-500 spectrometer equipped with a
field gradient H-X probe at 313 K. The 1H and
13C NMR assignments were obtained by one-dimensional
(1H and 13C) and two-dimensional NMR (double
quantum-filtered COSY, double quantum-filtered NOESY, and TOCSY)
experiments. Double quantum-filtered NOESY spectra (20 ppm sweep width,
1,024 points in F2 and 512 points in F1, 128 scans per F1 block) were
obtained with mixing times ranging from 20 to 200 ms and zero-filled to
2,048 × 2,048 complex points before Fourier transformation. The
1% shifted sine squared bell window was used for F2, and the 3%
sifted sine squared bell window was used for the F1 dimension. TOCSY
spectra (20 ppm spectral width, 1,024 points in F2 and 512 points in
F1, 256 scans per F2 block) were recorded with spin-locking times
ranging from 50 to 100 ms and treated in the same way as for the NOESY
spectra. Phase-sensitive NOESY spectra (20 ppm spectral width, 1,024 points in F2 and 512 points in F2, 384 scans per F2 block) were
measured with mixing times ranging from 20 to 200 ms. The 3% sifted
sine squared bell for F2 and the 5% sifted sine squared bell were used for window functions. All NMR calculations were performed on an SGI
work station O2 with the Lambda program (JEOL).
Constraints--
The obtained nuclear Overhauser effects were
classified as strong, medium, weak, and very weak, corresponding to the
interproton distance constraints of 2.0-2.5, 2.0-3.0, 2.0-4.0, and
2.0-5.0 Å, respectively. For the upper distance limits for nuclear
Overhauser effect distances involving methyl protons,
nonstereospecifically assigned methylene protons and aromatic ring
protons as well as pseudo-atom corrections were applied of 1.0, 0.9, and 2.0 Å, respectively. The final distance geometry (DG) structures
of calcium-free PLA2 were calculated based on 1,616 constraints (448 for the intraresidue, 535 for the sequential
interresidue, 329 for the medium range, and 304 for the long range).
For the calculation of the final DG structures of calcium-bound
PLA2, 1,593 constraints (437 for the intraresidue, 437 for
the sequential interresidue, 332 for the medium range, and 298 for the
long range) were used.
Structure Calculations and Iterative Structure
Refinements--
All structure calculations were carried out using the
InsightII/Discover-2000 software package (MSI, San Diego, CA) on an SGI
work station O2. Starting structures for calcium-free and calcium-bound
enzymes were generated with distance geometry using the DGII module.
The obtained starting structure was initially subjected to 100 steps of
steepest descent minimization followed by 1,500 iterations using
conjugate gradient minimization and then by restrained molecular
dynamics for 6 ps, using a consistent valence force field (26).
Finally, another energy minimization step was performed (250 steepest
descent steps followed by 2,500 iterations using conjugate-gradient
minimization) to give initial structures. The final structures were
calculated by using an iterative structure refinement, as described in
the literature (27). The atomic coordinates of the NMR structure of the
enzyme together with the constraints and the chemical shifts have been
deposited in the Protein Data Bank.
 |
RESULTS AND DISCUSSION |
Properties of PLA2 Produced by S. violaceoruber--
The product analysis by gas chromatography showed
that an enzyme sample, partially purified from the supernatant from the culture broth of S. violaceoruber A-2688, liberated oleic
acid from 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine, suggesting that the enzyme sample, extracellularly produced by the bacterium, contributed to hydrolyze the 2-ester bond of
1,2-diacyl-3-sn-phosphoglycerides. Thus, this enzyme sample
seemed to contain PLA2. We purified the putative S. violaceoruber PLA2 to homogeneity and confirmed that it certainly was PLA2 by the same gas chromatographic
experiment. The molecular weights of the PLA2, estimated by
SDS-PAGE and Sephadex G-100, were 14,000 and 15,000 daltons (± 1,000),
respectively, suggesting that the S. violaceoruber
PLA2 is a monomeric enzyme with almost the same size as
PLA2 from eukaryotic sources. The isoelectric point was
7.5, and the pH optimum for enzyme reaction is 7.3-8.3, when measured
using a 20 mM Britton-Robinson buffer. The enzyme was
stable at 50 °C for 10 min in a 20 mM Britton-Robinson buffer (pH 8.0) in the presence of 50 mM CaCl2.
The PLA2 reaction was activated and inhibited by the
addition of calcium ion and EDTA, respectively.
Various phospholipids differing in the polar head groups are known.
When the relative activity of the S. violaceoruber
PLA2 to PC is defined to be 100%, those of
phosphatidylethanolamine and phosphatidic acid were 30 and 10%,
respectively. Lysophosphatidylcholine was not useful as a substrate of
bacterial PLA2. However, human synovial PLA2
hydrolyzes phosphatidylethanolamine more effectively than
phosphatidylserine and PC (28).
S. violaceoruber A-2688 produced 0.5 units of
PLA2 per ml at a large scale in a 20-liter liquid medium
consisting of tryptic soy broth. Twenty mg of purified PLA2
was obtained from the 20-liter culture broth.
Cloning and Sequencing of a PLA2-encoding Gene--
To
clone a gene encoding the S. violaceoruber PLA2,
we determined the amino acid sequences of the resulting peptide
fragments of PLA2 digested with and without endoproteinase
Asp-N or lysyl endopeptidase. Fig. 2
shows the N-terminal sequences of the undigested protein and the
resulting peptide fragments used for the design of mixed probes. Four
kinds of mixed probes (probes 1-4) were synthesized, as shown in Fig.
2. The N-terminal sequence of the undigested protein was used for the
design of probe 4. A genomic library of the S. violaceoruber, prepared in E. coli vector pUC118, was
screened with probe 3, and, by colony hybridization, a candidate clone
was obtained from a population of about 10,000 colonies. A partial
restriction map of a 2.5-kb insert of the Streptomyces DNA
contained in a plasmid having a size of 5.7 kb, designated pPLA51,
which had been isolated from this clone, was determined (Fig.
3a). Probes 1, 2, and 4 also
hybridized to the BglI-SphI DNA fragment
shortened to 0.5 kb, as did probe 3, suggesting that at least a part of
the PLA2 structural gene is present within the 0.5-kb
fragment.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
N-terminal sequence of the mature
S. violaceoruber PLA2 and the
peptide fragments isolated after digestion of the protein with
endoproteinase. Asp-N or lysyl endopeptidase and design of the
mixed probes to clone a PLA2-encoding gene. The amino acid
sequence used for the design of probe 4 shows the N terminus of the
mature PLA2.
|
|

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 3.
a, a partial restriction endonuclease
map of the 2. 5-kb cloned Streptomyces DNA fragment carrying
the PLA2 gene in the plasmid pPLA51. b, the
nucleotide sequence of the 0.5-kb fragment containing the
PLA2 gene. The consensus Shine-Dalgarno sequence is
indicated by double underlining. The putative
signal sequence necessary for the secretion of the enzyme is
underlined. The N-terminal amino acid sequence of the
PLA2, determined by the Edman degradation method, is shown
by a dotted line. Amino acids that were not
determined by the Edman degradation method are shown without the dotted
line. Cys residues, which form disulfide bonds, are enclosed by a
circle. An arrow indicates a putative cleavage
site for the Streptomyces signal peptidase. In this figure,
the N-terminal Met residue in the precursor PLA2, which
contains the signal peptide sequence, was numbered as 1. The nucleotide
sequence data reported here have been deposited in the
DDBJ/EMBL/GenBankTM databases under accession E08479.
|
|
The DNA fragment was sequenced by the modified dideoxy chain
termination method using 7-deaza-dGTP instead of dGTP (29). Fig.
3b shows the nucleotide sequence of the
PLA2-encoding gene, together with the 5'- and 3'-adjacent
regions. An open reading frame consisting of 453 bp starts at GTG
(G = +1) and ends at TGA (T = +454) and is predicted to
encode a protein with a molecular size of 16,463. Instead of ATG, a
codon (GTG) for Val may be used as an initiation codon. The amino acid
sequence of the protein deduced from the nucleotide sequence was
confirmed by determination of the amino acid sequences of the
undigested protein and peptide fragments obtained by digestion with two
kinds of peptidase. The dotted lines in Fig.
3b show the amino acid sequence confirmed by the peptide
analysis, indicating that we had indeed cloned the PLA2
gene. The nucleotide sequence for four mixed probes is surely present
in the cloned DNA fragment. As shown in Fig. 3b, the
N-terminal methionine residue of the precursor PLA2
containing the signal peptide sequence is numbered as 1, and the amino
acid sequence of the undigested PLA2 reveals that the
mature PLA2 consists of
Ala30-Gly151 residues and has a molecular size
of 13,558. The value is roughly equal to that estimated by SDS-PAGE and
gel filtration chromatography using Sephadex G-100. Therefore, the
amino acid sequence from Val1 to Ala29 is
considered to be an essential signal sequence for secreted proteins.
The Shine-Dalgarno sequence (GGAGG) (30), found in the E. coli gene, is present at 7 bp upstream from the start codon (GTG)
of the PLA2 gene. Surprisingly, amino acid sequence
containing the signal peptide of the S. violaceoruber
PLA2 has 100% identity to that of a hypothetical protein
deduced from the genome sequence of S. coelicolor, which is
determined by the Sanger Centre and deposited in GenomeNet FASTA server
(version 3.4t05, August 18, 2001). The data base also indicates that
the amino acid sequence of the S. violaceoruber
PLA2 has about 45% identity to that of a fungal
PLA2 having a molecular mass of 23 kDa (31).
Overproduction of PLA2 in S. lividans--
The plasmid
pPLA51, digested with BamHI, was ligated to
BamHI-digested pIJ680, which is a vector for
Streptomyces. The chimeric plasmid was introduced into
protoplasts from S. lividans TK24 and spread on a
regeneration medium containing thiostrepton. The recombinant plasmid,
isolated from a thiostrepton-resistant transformant, was designated
pPLA101. S. livisans TK24 harboring pPLA101 was grown at
28 °C for 3 days at a small scale of 100 ml in Tryptic soy broth
supplemented with 10 µg/ml thiostrepton. By centrifugation at
13,000 × g for 10 min, the supernatant fluid and
mycelium were separated. The mycelium was washed with a 10 mM Tris-HCl buffer (pH 8.0), dissolved with the same
buffer, and sonicated. The high activity (1.04 units/ml) of
PLA2 was observed in the supernatant fluid but scarcely
(0.07 units/ml) in the cell-free extract. Judging from the fact that
the PLA2-encoding gene was inserted at the opposite
direction into a Streptomyces vector pIJ680, the gene must
be transcribed via its own promoter but not via read-through from the
vector. We confirmed that S. lividans carrying the
cloned-PLA2 extracellularly produced at least a 20-fold
higher PLA2 than the original S. violaceoruver.
In this study, the enzyme produced by S. lividans TK24
harboring pPLA101 is called "recombinant PLA2 " in the
following description. The characteristics of the recombinant PLA2, such as molecular weight, isoelectric point,
thermostability, and substrate specificity, were the same as those of
the S. violaceoruber PLA2.
Properties of the Recombinant PLA2--
For product
determination of the enzyme-catalyzed hydrolysis, we conducted the
reaction of 1,2-dipalmitoyl-L-
-phosphatidylcholine (37 mg) and the recombinant PLA2 (~0.1 mg) in aqueous 5 mM CaCl2 (5 ml) at 25 °C and pH 8.0. After
5 h, one equivalent amount of OH
(i.e.
0.1 M NaOH, 0.5 ml) was consumed to keep the pH. The
solvent was evaporated, and then the residue was dissolved in
CD3OD (2 ml). The methanol-soluble product was identified
by 1H NMR to be
1-palmitoyl-L-
-lysophosphatidylcholine without any other
compound, such as 2-palmitoyl analogue. These facts show that the
enzyme promotes selective hydrolysis at the 2-acyl ester bond to form
the corresponding lysophosphatidylcholine (see Fig. 1).
We determined the calcium(II) dissociation constant,
Kd, of the recombinant PLA2 using PC as
a substrate. The calcium(II) concentration increases as the PC
hydrolysis rate (V) increases (see "Experimental
Procedures"). A Lineweaver-Burk plot of 1/V against
1/[Ca2+] gives a straight line (Fig.
4), indicating 1:1 calcium (II) complexation at the active center of the PLA2. From the
x-intercept (1/Kd) of the line, the
Kd values at 25 and at 35 °C were estimated to be
4.5 ± 0.2 and 5.3 ± 0.2 mM, respectively. The
calcium(II) dissociation constant of the S. violaceoruber PLA2 is much larger than those of eukaryotic
PLA2s (e.g. 0.25 mM for the
pancreatic PLA2 (32) and 0.13 mM for cobra
venom PLA2s (33). This fact indicates that the prokaryotic
PLA2 is a novel enzyme in the PLA2
superfamily.
NMR Structure of the Calcium-bound Prokaryotic
PLA2--
The primary structure of the
Streptomyces mature PLA2, except the residues
from Cys61 to Thr68, was different from those
of eukaryotic secreted PLA2s (5). In order to investigate
the three-dimensional structural difference between prokaryotic and
eukaryotic PLA2s, we determined the NMR structure of the
calcium-bound prokaryotic PLA2 in aqueous solution.
A total of 30 DG structures for the calcium-bound PLA2 were
calculated without the constraints of calcium(II) ion. After inspection of the 30 DG structures for chirality, distance, and dihedral angle
violations, 28 structures were refined. The obtained 28 structures
displayed distance violations of less than 0.7 Å or
angle
violations of less than 20°. At the refinement stage for the final
structure determination, we adopted the constrains of 2.0 - 4.0 Å for
the coordination bonds between calcium(II) ion and the carboxylates of
Asp43 and Asp65. After analysis for low total
energies and violation energies, a final set of 15 refined structures
for the calcium-bound PLA2 was obtained. The superposition
of backbone atoms of the 15 refined structures is shown in Fig.
5. An average structure of the 15 refined
structures is displayed in Fig. 6. The
root mean square difference between the 15 conformers and the averaged
structure is 0.65 ± 0.08 Å for the backbone atoms and 1.15 ± 0.07 Å for all atoms. When the disordered N- and C-terminal
residues, Ala1, Pro2, Ala3,
Ile120, Phe121, and Gly122, were
not considered for the calculation, the root mean square values
decreased to 0.48 ± 0.06 Å for the backbone atoms and 0.89 ± 0.04 Å for all atoms. The average of the distance constraint violations for the 15 refined structures was smaller than 0.5 Å. The
average of the five
angle torsion constraint violations for the 15 refined structures was smaller than 6°.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Stereoviews showing best fit superpositions
of the backbone atoms (N, C , C') for the 15 refined distance geometry structures of calcium-bound
PLA2.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Stereoview of the final NMR structure of the
calcium-bound S. violaceoruber PLA2.
Calcium(II) ion is shown as a red ball. Two
disulfide bonds, the Asp85 His64 pair, and the
Arg69 residue are colored in yellow,
cyan, and magenta, respectively. The N-terminal
Ala residue in the mature PLA2 is numbered as 1.
|
|
The sterochemical structure of the amino acids and the dihedral angles
in the 15 refined structures were checked with PROCHECK (34). A
Ramachandran plot of the average structure of the calcium-bound PLA2 is shown in Fig. 7. The
backbone dihedral angles, except for Leu44, fall within the
core regions of the plot. This fact supports the idea that the carbonyl
oxygen of Leu44 coordinates to calcium(II) ion, and the
backbone is thus twisted toward Asp65. The structure around
the calcium(II) ion in the calcium-bound PLA2 is
displayed in Fig. 8a.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 7.
A Rmamachandran
/ plot for the final NMR
structure of the calcium-bound S. violaceoruber
PLA2 by using the program PROCHECK (34). Data
for Gly and the other residues are given as open squares and
closed circles, respectively.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 8.
Stereoview (a) and geometry
change (b) of the calcium-binding site in the S. violaceoruber PLA2. The calcium-free and
calcium-bound forms are displayed in yellow and
cyan, respectively. The calcium(II) ion is shown as a
red ball. The N-terminal Ala residue in the
mature PLA2 is numbered as 1.
|
|
All class I/II PLA2s contain about 50%
-helix and an
anti-parallel
-sheet, whereas the prokaryotic PLA2
consists of only five
-helices (
1,
2,
3,
4, and
5) without a
-sheet (see Fig. 6). The structure of the prokaryotic
PLA2 is divided into two parts; one is the N-terminal
domain including two
-helices (
1 and
2), and the other is the C-terminal domain including three
-helices (
3,
4, and
5). A long loop composed of the residues from
Glu37 to Phe57 connects the two helical
domains. The direction of the
4-helix is anti-parallel
to those of the
3-helix and the
5-helix.
The
3-helix is perpendicular to the
2-helix. PLA2s from eukaryotic sources have
6-8 disulfide bonds, whereas the S. violaceoruber PLA2 has only four cysteine residues (Fig. 3b),
suggesting two disulfide bonds. In fact, the NMR structure of the
prokaryotic PLA2 discloses the two disulfide bonds of
Cys41
Cys65 and
Cys96
Cys107 (see Fig. 6). It is noteworthy
that two disulfide bonds are enough to maintain the conformational
rigidity for the enzyme activity.
Comparison of the Calcium-free Form with the Calcium-bound Form of
PLA2--
An almost identical NMR analysis of the
bacterial calcium-free PLA2 gave an NMR structure similar
to that of the calcium-bound PLA2. Some proton signals
assigned to the Asp43, Leu44,
Cys61, and Asp65 residues in the calcium-free
PLA2 shifted to the higher field compared with those for
the calcium-bound form. This observation supports the idea that
calcium(II) ion stays in the vicinity of these amino acids, which is
consistent with the NMR structure for the calcium-bound
PLA2 (see Fig. 8). A remarkable structural difference
between the calcium-free and calcium-bound PLA2 is seen in
a
-turn region composed of the Cys45
Ala48
residues. The turn region for the calcium-bound PLA2 is
more rigid compared with the calcium-free form, which is due to the calcium(II) complexation.
Another structural difference is in the configuration of
Asp43 in the calcium-free form; the Asp43
carboxylic group makes an electrostatic interaction with the Arg69 guanidine group. When the calcium ion approaches the
calcium-binding site, a hydrogen bond between Arg69 and
Asp43 dissociates, and four oxygen donors
(Asp43, Asp65, and Leu44)
simultaneously associate with the calcium(II) ion. The resulting free
guanidyl cation of Arg69 may assist the binding with the
anionic phosphodiester group of PC (a substrate). Fig. 8b
shows the geometry change of the calcium-binding site in the
PLA2. The carboxylate coordination modes of
Asp43 and Asp65 are monodentate and bidentate,
respectively. The coordination polyhedron is completed by three water
molecules and by the peptide-carbonyl group of Leu44,
resulting in a coordination number of 7. The estimated bond lengths for
Ca
O(Asp43), Ca
O(Asp65), and
Ca
O(Leu44) are 2.3, 2.5, and 3.5 Å, respectively. A
charge-relay system, His64 and Asp85 residues
linked by a hydrogen bond, is close to the water coordination site,
which would be in the substrate-binding pocket (see Fig. 6). A nitrogen
atom of His64, which may act as a general base-catalyst, is
5.5 Å apart from the calcium(II) ion. Similar alignments of imidazole
and carboxylate groups are well known in the active center of the other
calcium-dependent PLA2s, such as porcine
pancreatic PLA2 (12).
The solution analysis concludes that the S. violaceoruber
PLA2 has a strikingly novel folding topology. Searching for
structures with a fold similar to that of the S. violaceoruber PLA2 in the DALI data base (35) showed
that no similar protein structures were found. The evolutionary origin
of S. violaceoruber PLA2 appears to be different
from not only that of eukaryotic PLA2s but also that of all
other proteins registered in the Protein Data Bank. Other research
groups have proposed that the PLA2s discovered until now
can be divided into twelve groups, designated groups I-XII (21, 22).
In agreement with their proposal, we can propose a new group for the
S. violaceoruber PLA2.
The fatty acids released by PLA2 can be important as stores
of energy, but, more importantly, arachidonic acid can also function as
a second messenger and the precursor of eicosanoids, which are potent
mediators of inflammation and signal transduction. What role does the
S. violaceoruber PLA2, which is the secreted enzyme, play in the pathogenesis of the bacterium? As shown in this
study, the most preferred substrate for the secreted bacterial PLA2 is PC. In addition, the high concentration of the
calcium(II) ion (Kd = ~5 mM) is
necessary for expression of the enzyme activity. Furthermore,
Streptomyces cells do not have PC as the membrane component
(36). A human PLA2, which is contained in platelets and
enriched in rheumatoid synovial fluid, shows a striking preference for
phospholipids presented in the E. coli membranes (37). These
facts suggest that S. violaceoruber cells must be protected
from the digestive effect of their own PLA2. There is a
possibility that the Streptomyces cells might produce the
secreted PLA2 to take ecological priority among
microorganisms living in a soil. In other words, the bacterial
PLA2 might function as a toxin to kill microorganisms
having phosphatidylcholine as a membrane component.
 |
FOOTNOTES |
*
We have applied for a patent for S. violaceoruber and S. lividans carrying the cloned
PLA2 gene with the Patent Office, Japan, as an invention
entitled "Essentially Pure Microorganisms That Produce
PLA2."The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) E08479.
The atomic coordinates and the structure factors (code 1lT4 and 1lT5) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§
To whom correspondence should be addressed. Tel.: 81-82-257-5280;
Fax: 81-82-257-5284; E-mail: sugi@hiroshima-u.ac.jp.
Present address: Dept. of Chemistry and Material Engineering,
Ibaraki National College of Technology, Nakane 866, Hitachinaka, Ibaraki 312-8508, Japan.
Published, JBC Papers in Press, March 15, 2002, DOI 10.1074/jbc.M200264200
 |
ABBREVIATIONS |
The abbreviations used are:
PLA2
phospholipase A2, DG, distance geometry;
EPPS, 3-[4-(2-hydroxyethyl)-1-piperazinyl]-propanesulfonic acid;
NOESY, nuclear Overhauser effect correlation spectroscopy;
PC, phosphatidylcholine;
PIPES, piparazine-1,4-bis(2-ethanesulfonic acid);
TOCSY, total correlation spectroscopy;
HPLC, high pressure liquid
chromatography.
 |
REFERENCES |
| 1.
|
Dennis, E. A.
(1994)
J. Biol. Chem.
269,
13057-13060[Free Full Text]
|
| 2.
|
Dennis, E. A.
(1987)
Drug. Dev. Res.
10,
205-220[CrossRef]
|
| 3.
|
Irvine, R. F.
(1982)
Biochem. J.
204,
3-16[Medline]
[Order article via Infotrieve]
|
| 4.
|
Dennis, E. A.
(1987)
Biotechnology
5,
1294-1300[CrossRef]
|
| 5.
|
Davidson, F. F.,
and Dennis, E. A.
(1990)
J. Mol. Evol.
31,
228-238[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Kini, R. M.,
and Evans, H. J.
(1989)
Toxicon
27,
613-635[Medline]
[Order article via Infotrieve]
|
| 7.
|
Hawgood, B.,
and Bon, C.
(1991)
in
Handbook of Natural Toxins: Reptile Venoms and Toxins
(Tu, A. T., ed), Vol. 5
, pp. 3-52, Marcel Dekker, New York
|
| 8.
|
de Haas, G. H.,
Postema, N. M.,
Nieuwenhuizen, W.,
and van Deenen, L. L. M.
(1968)
Biochim. Biophys. Acta
159,
118-129[Medline]
[Order article via Infotrieve]
|
| 9.
|
Hanada, K.,
Kinoshita, E.,
Itoh, M.,
Kajiyama, G.,
and Sugiyama, M.
(1995)
FEBS Lett.
373,
85-87[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Kinoshita, E.,
Handa, N.,
Hanada, K.,
Kajiyama, G.,
and Sugiyama, M.
(1997)
FEBS Lett.
407,
343-346[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Kinoshita, E.,
Hanada, K.,
Itoh, M.,
Kumagai, T.,
Kajiyama, G.,
and Sugiyama, M.
(1996)
Int. J. Oncol.
9,
1219-1225
|
| 12.
|
van den Berg, B.,
Tessari, M.,
de Hass, G. H.,
Verheij, H. M.,
Boelens, R.,
and Kaptein, R.
(1995)
EMBO J.
14,
4123-4131[Medline]
[Order article via Infotrieve]
|
| 13.
|
Dijkstra, B. W.,
Kalk, K. H.,
Hol, W. G. J.,
and Drenth, J.
(1981)
J. Mol. Biol.
147,
97-123[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Brunie, S.,
Bolin, J.,
Gewirth, D.,
and Sigler, P. B.
(1985)
J. Biol. Chem.
260,
9742-9749[Abstract/Free Full Text]
|
| 15.
|
Thunnissen, M. M. G. M., AB, E.,
Kalk, K. H.,
Drenth, J.,
Dijkstra, B. W.,
Kuipers, O. P.,
Dijkman, R.,
de Haas, G. H.,
and Verheij, H. M.
(1990)
Nature
347,
689-691[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Scott, D. L.,
White, S. P.,
Otwinowski, Z.,
Yuan, K.,
Gelb, M. H.,
and Sigler, P. B.
(1990)
Science
250,
1541-1546[Abstract/Free Full Text]
|
| 17.
|
Scott, D. L.,
Otwinowski, Z.,
Gelb, M. H.,
and Sigler, P. B.
(1990)
Science
250,
1563-1566[Abstract/Free Full Text]
|
| 18.
|
White, S. P.,
Scott, D. L.,
Otwinowski, Z.,
Gelb, M. H.,
and Sigler, P. B.
(1990)
Science
250,
1560-1563[Abstract/Free Full Text]
|
| 19.
|
Wery, J. P.,
Schevitz, R. W.,
Clawson, D. K.,
Bobbitt, J. L.,
Dow, E. R.,
Gamboa, G.,
Goodson, T., Jr.,
Hermann, R. B.,
Kramer, R. M.,
McClure, D. B.,
Mihelich, E. D.,
Putnam, J. E.,
Sharp, J. D.,
Stark, D. H.,
Teater, C.,
Warrick, M. W.,
and Jones, N. D.
(1991)
Nature
352,
79-82[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Dijkstra, B. W.,
van Nes, G. J. H.,
Kalk, K. H.,
Brandenburg, N. P.,
Hol, W. G. J.,
and Drenth, J.
(1982)
Acta Crystallogr. B
38,
793-799
|
| 21.
|
Six, D. A.,
and Dennis, E. A.
(2000)
Biochim. Biophys. Acta
1488,
1-19[Medline]
[Order article via Infotrieve]
|
| 22.
|
Gelb, M. H.,
Valentin, E.,
Ghomashchi, F.,
Lazdunski, M.,
and Lambeau, G.
(2000)
J. Biol. Chem.
275,
39823-39826[Abstract/Free Full Text]
|
| 23.
|
McIntosh, J. M.,
Ghomashchi, F.,
Gelb, M. H.,
Dooley, D. J.,
Stoehr, S. J.,
Giordani, A. B.,
Maisbitt, S. R.,
and Olivera, B. M.
(1995)
J. Biol. Chem.
270,
3518-3526[Abstract/Free Full Text]
|
| 24.
|
Suzuki, K.,
Ogishima, M.,
Sugiyama, M.,
Inouye, Y.,
Nakamura, S.,
and Imamura, S.
(1992)
Biosci. Biotechnol. Biochem.
56,
432-436[Medline]
[Order article via Infotrieve]
|
| 25.
|
Hopwood, D. A.,
Bibb, M. J.,
Chater, K. F.,
Kiser, T.,
Bruton, C. J.,
Kiser, H. M.,
Lydiate, D. J.,
Smith, C. P.,
Ward, J. M.,
and Schrempf, H.
(1985)
Genetic Manipulation of Streptomyces: A Laboratory Manual
, John Innes Foundation, Norwich, UK
|
| 26.
|
Dauber-Osguthorpe, P.,
Roberts, V. A.,
Osguthorpe, D. J.,
Wolff, J.,
Genest, M.,
and Hagler, A. T.
(1988)
Proteins Struct. Funct. Genet.
4,
31-47[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Powers, R.,
Garrett, D. S.,
March, C. J.,
Frieden, E. A.,
Gronenborn, A. M.,
and Clore, G. M.
(1993)
Biochemistry
32,
6744-6762[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Hrara, S.,
Kudo, I.,
Chang, H. W.,
Matsuta, K.,
Miyamoto, T.,
and Inoue, K.
(1989)
J. Biochem. (Tokyo)
105,
395-399[Abstract/Free Full Text]
|
| 29.
|
Mizusawa, S.,
Nishimura, S.,
and Seela, F.
(1986)
Nucleic Acids Res.
14,
1319-1324[Abstract/Free Full Text]
|
| 30.
|
Shine, J.,
and Dalgarno, L.
(1974)
Proc. Natl. Acad. Sci. U. S. A.
71,
1342-1346[Abstract/Free Full Text]
|
| 31.
|
Solagni, E.,
Bolchi, A.,
Balestrini, R.,
Gambaretto, C.,
Percudani, R.,
Bonfante, P.,
and Ottonello, S.
(2001)
EMBO J.
20,
5079-5090[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Drankenberg, T.,
Andersson, T.,
Forsen, S.,
and Wieloch, T.
(1984)
Biochemistry
23,
2387-2392[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Teshima, K.,
Ikeda, K.,
Hamaguchi, K.,
and Hayashi, K.
(1981)
J. Biochem. (Tokyo)
89,
13-20[Abstract/Free Full Text]
|
| 34.
|
Morris, A. L.,
MacArthur, M. W.,
Hutchinson, E. G.,
and Thornton, J. M.
(1992)
Proteins
12,
345-364[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Holm, L.,
and Sander, C.
(1993)
J. Mol. Biol.
233,
123-138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Lechevalier, M. P.,
de Bievre, C.,
and Lechevalier, H.
(1977)
Biochem. Syst. Ecol.
5,
249-280[CrossRef]
|
| 37.
|
Karmer, R. M.,
Hession, C.,
johansen, B.,
Hayes, G.,
McGray, P.,
Chow, E. P.,
Tizard, R.,
and Pepinsky, R. B.
(1989)
J. Biol. Chem.
264,
5768-5775[Abstract/Free Full Text]
|
| 38.
|
Matoba, Y.,
Katsube, Y.,
and Sugiyama, M.
(2002)
J. Biol. Chem.
277,
20059-20069[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Guillaume, C. Calzada, M. Lagarde, J. Schrevel, and C. Deregnaucourt
Interplay between lipoproteins and bee venom phospholipase A2 in relation to their anti-plasmodium toxicity
J. Lipid Res.,
July 1, 2006;
47(7):
1493 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Nagiec, B. Lei, S. K. Parker, M. L. Vasil, M. Matsumoto, R. M. Ireland, S. B. Beres, N. P. Hoe, and J. M. Musser
Analysis of a Novel Prophage-encoded Group A Streptococcus Extracellular Phospholipase A2
J. Biol. Chem.,
October 29, 2004;
279(44):
45909 - 45918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Matoba, Y. Katsube, and M. Sugiyama
The Crystal Structure of Prokaryotic Phospholipase A2
J. Biol. Chem.,
May 24, 2002;
277(22):
20059 - 20069.
[Abstract]
[Full Text]
[PDF]
|
 |
|